Inhaled recombinant human granulocyte-macrophage colony-stimulating factor (GM-CSF) needed to clear lung surfactant improved ...

A persistent cough may seem harmless, but in rare cases it could signal pulmonary fibrosis, a serious lung-scarring condition ...

Rheumatoid arthritis may play a causal role in idiopathic pulmonary fibrosis but not vice versa, with some shared plasma ...

For the first time, people with bronchiectasis will have a treatment option. The U.S. Food and Drug Administration (FDA) has ...

Idiopathic pulmonary fibrosis (IPF) is a chronic and progressive lung disease characterized by the excessive accumulation of ...

The inverse variance-weighted analysis suggested that large artery atherosclerosis stroke had a negative impact on IPF risk, ...

This paper presents the pulmonary acoustic sensor telemetry array, a novel hardware prototype developed for remote pulmonary monitoring, diagnosis, and prognostication of pulmonary sounds in clinical ...

Trikafta, for cystic fibrosis, is due to be added to WHO's Essential Medicines List. But its pricing means many patients are unable to access it. Sophie Cousins reports.

A new study meticulously sampled different lung regions in people with cystic fibrosis to understand why infections persist after new treatments.

GRI-0621 appears to reduce markers of fibrosis in people with idiopathic pulmonary fibrosis, interim clinical trial data suggest.